体外动态组合筛选能够抑制（CUG）重复RNA与MBNL1相互作用的分子：发现靶向强直性肌营养不良（DM1）的先导化合物
Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1).
作者信息
Gareiss Peter C, Sobczak Krzysztof, McNaughton Brian R, Palde Prakash B, Thornton Charles A, Miller Benjamin L
机构信息
Department of Biochemistry and Biophysics, University of Rochester, Rochester, New York 14642, USA.
出版信息
J Am Chem Soc. 2008 Dec 3;130(48):16254-61. doi: 10.1021/ja804398y.
Abstract
Myotonic dystrophy type 1 (DM1), the most common form of muscular dystrophy in adults, is an RNA-mediated disease. Dramatically expanded (CUG) repeats accumulate in nuclei and sequester RNA-binding proteins such as the splicing regulator MBNL1. We have employed resin-bound dynamic combinatorial chemistry (RBDCC) to identify the first examples of compounds able to inhibit MBNL1 binding to (CUG) repeat RNA. Screening an RBDCL with a theoretical diversity of 11 325 members yielded several molecules with significant selectivity for binding to (CUG) repeat RNA over other sequences. These compounds were also able to inhibit the interaction of GGG-(CUG)(109)-GGG RNA with MBNL1 in vitro, with K(i) values in the low micromolar range.
摘要
1型强直性肌营养不良症（DM1）是成人中最常见的肌营养不良症形式，是一种RNA介导的疾病。大量扩增的（CUG）重复序列在细胞核中积累，并隔离诸如剪接调节因子MBNL1等RNA结合蛋白。我们采用树脂结合动态组合化学（RBDCC）来鉴定能够抑制MBNL1与（CUG）重复RNA结合的首批化合物实例。对一个理论多样性为11325个成员的RBDCL进行筛选，得到了几个对（CUG）重复RNA具有显著选择性的分子，其对其他序列的结合选择性更高。这些化合物在体外也能够抑制GGG-（CUG）（109）-GGG RNA与MBNL1的相互作用，抑制常数（K i）值在低微摩尔范围内。
相似文献
1
Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1).体外动态组合筛选能够抑制（CUG）重复RNA与MBNL1相互作用的分子：发现靶向强直性肌营养不良（DM1）的先导化合物
J Am Chem Soc. 2008 Dec 3;130(48):16254-61. doi: 10.1021/ja804398y.
2
CUG repeat RNA-dependent proteasomal degradation of MBNL1 in a cellular model of myotonic dystrophy type 1.CUG 重复 RNA 依赖性蛋白酶体降解 1 型肌强直性营养不良细胞模型中的 MBNL1。
Biochem Biophys Res Commun. 2024 Nov 12;733:150729. doi: 10.1016/j.bbrc.2024.150729. Epub 2024 Sep 21.
3
Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.用双脒基抑制剂靶向导致1型强直性肌营养不良症（DM1）的毒性RNA。
J Am Chem Soc. 2014 Apr 30;136(17):6355-61. doi: 10.1021/ja5012146. Epub 2014 Apr 22.
4
MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.MBNL1是DM1中焦点形成和胰岛素受体异常剪接的主要决定因素。
J Biol Chem. 2005 Feb 18;280(7):5773-80. doi: 10.1074/jbc.M410781200. Epub 2004 Nov 16.
5
Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.鉴定对Ⅰ型强直性肌营养不良具有治疗潜力的植物源生物碱。
J Biol Chem. 2016 Aug 12;291(33):17165-77. doi: 10.1074/jbc.M115.710616. Epub 2016 Jun 13.
6
Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.扩展的 CUG 重复通过改变肌肉盲 1 复合物的化学计量来扰乱 RNA 剪接。
J Biol Chem. 2011 Nov 4;286(44):38427-38438. doi: 10.1074/jbc.M111.255224. Epub 2011 Sep 7.
7
Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.肌强直性营养不良中，肌盲蛋白与RNA病灶的共定位与可变剪接的失调是可分离的。
J Cell Sci. 2005 Jul 1;118(Pt 13):2923-33. doi: 10.1242/jcs.02404. Epub 2005 Jun 16.
8
Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).分析 1 型肌强直性营养不良（DM1）和 2 型肌强直性营养不良（DM2）青少年/成人发病患者中 MTMR1 的表达及其与肌肉病理特征的相关性。
Exp Mol Pathol. 2010 Oct;89(2):158-68. doi: 10.1016/j.yexmp.2010.05.007. Epub 2010 Jun 1.
9
From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy.从动态组合的“命中”到先导物：针对导致肌营养不良症的致病 RNA 的化合物的体外和体内活性。
Nucleic Acids Res. 2012 Jul;40(13):6380-90. doi: 10.1093/nar/gks298. Epub 2012 Apr 6.
10
Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.呋咱甲氢龙通过多种机制挽救肌强直性营养不良 1 型相关的剪接错误。
ACS Chem Biol. 2018 Sep 21;13(9):2708-2718. doi: 10.1021/acschembio.8b00646. Epub 2018 Aug 27.
引用本文的文献
1
Drug delivery agent that acts as a drug for synergistic activity.作为具有协同活性药物的药物递送剂。
iScience. 2025 Jun 13;28(8):112890. doi: 10.1016/j.isci.2025.112890. eCollection 2025 Aug 15.
2
Dynamic combinatorial chemistry directed by proteins and nucleic acids: a powerful tool for drug discovery.由蛋白质和核酸导向的动态组合化学：药物发现的强大工具。
Chem Soc Rev. 2025 Jul 8. doi: 10.1039/d5cs00223k.
3
Fragment-Based Approaches to Identify RNA Binders.基于片段的方法鉴定 RNA 结合物。
J Med Chem. 2023 May 25;66(10):6523-6541. doi: 10.1021/acs.jmedchem.3c00034. Epub 2023 May 15.
4
Selective and Reversible Ligand Assembly on the DNA and RNA Repeat Sequences in Myotonic Dystrophy.选择性和可逆性配体组装在肌强直性营养不良的 DNA 和 RNA 重复序列上。
Chembiochem. 2022 Sep 5;23(17):e202200260. doi: 10.1002/cbic.202200260. Epub 2022 Jul 19.
5
RNA-Binding Macrocyclic Peptides.RNA结合大环肽
Front Mol Biosci. 2022 Apr 19;9:883060. doi: 10.3389/fmolb.2022.883060. eCollection 2022.
6
Recent advances in DNA-encoded dynamic libraries.DNA编码动态文库的最新进展。
RSC Chem Biol. 2022 Feb 17;3(4):407-419. doi: 10.1039/d2cb00007e. eCollection 2022 Apr 6.
7
Constrained peptides mimic a viral suppressor of RNA silencing.约束肽模拟病毒抑制 RNA 沉默的功能。
Nucleic Acids Res. 2021 Dec 16;49(22):12622-12633. doi: 10.1093/nar/gkab1149.
8
Review of machine learning methods for RNA secondary structure prediction.机器学习方法在 RNA 二级结构预测中的研究进展综述。
PLoS Comput Biol. 2021 Aug 26;17(8):e1009291. doi: 10.1371/journal.pcbi.1009291. eCollection 2021 Aug.
9
Systematically Studying the Effect of Small Molecules Interacting with RNA in Cellular and Preclinical Models.系统研究小分子与 RNA 在细胞和临床前模型中的相互作用。
ACS Chem Biol. 2021 Jul 16;16(7):1111-1127. doi: 10.1021/acschembio.1c00014. Epub 2021 Jun 24.
10
Massively Parallel Optimization of the Linker Domain in Small Molecule Dimers Targeting a Toxic r(CUG) Repeat Expansion.针对有毒r(CUG)重复扩增的小分子二聚体中接头结构域的大规模平行优化
ACS Med Chem Lett. 2021 Mar 2;12(6):907-914. doi: 10.1021/acsmedchemlett.1c00027. eCollection 2021 Jun 10.
本文引用的文献
1
Target-Accelerated Combinatorial Synthesis and Discovery of Highly Potent Antibiotics Effective Against Vancomycin-Resistant Bacteria.靶向加速组合合成与发现对耐万古霉素细菌有效的高效抗生素
Angew Chem Int Ed Engl. 2000 Nov 3;39(21):3823-3828. doi: 10.1002/1521-3773(20001103)39:21<3823::AID-ANIE3823>3.0.CO;2-3.
2
Two-vial, LC-MS identification of ephedrine receptors from a solution-phase dynamic combinatorial library of over 9000 components.从一个包含9000多种成分的溶液相动态组合库中，通过双瓶法进行液相色谱 - 质谱联用鉴定麻黄碱受体。
J Am Chem Soc. 2008 Sep 17;130(37):12218-9. doi: 10.1021/ja803317k. Epub 2008 Aug 21.
3
Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners.二维组合筛选确定了特定的氨基糖苷-RNA内部环配对物。
J Am Chem Soc. 2008 Aug 20;130(33):11185-94. doi: 10.1021/ja803234t. Epub 2008 Jul 25.
4
Targeting RNA with small molecules.用小分子靶向RNA。
Chem Rev. 2008 Apr;108(4):1171-224. doi: 10.1021/cr0681546. Epub 2008 Mar 25.
5
Small-molecule aggregates inhibit amyloid polymerization.小分子聚集体抑制淀粉样蛋白聚合。
Nat Chem Biol. 2008 Mar;4(3):197-9. doi: 10.1038/nchembio.65. Epub 2008 Jan 27.
6
Dynamic combinatorial mass spectrometry leads to metallo-beta-lactamase inhibitors.
J Med Chem. 2008 Feb 14;51(3):684-8. doi: 10.1021/jm070866g. Epub 2008 Jan 19.
7
Dynamic combinatorial chemistry: on the road to fulfilling the promise.动态组合化学：迈向兑现承诺之路
Org Biomol Chem. 2008 Jan 21;6(2):219-26. doi: 10.1039/b714599c. Epub 2007 Oct 29.
8
Guanidinoneomycin B recognition of an HIV-1 RNA helix.胍基新霉素B对HIV-1 RNA螺旋的识别。
Chembiochem. 2008 Jan 4;9(1):93-102. doi: 10.1002/cbic.200700251.
9
Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy.纠正ClC-1剪接可消除强直性肌营养不良小鼠模型中的氯离子通道病和肌强直。
J Clin Invest. 2007 Dec;117(12):3952-7. doi: 10.1172/JCI33355.
10
Myotonic dystrophy: RNA-mediated muscle disease.强直性肌营养不良症：RNA介导的肌肉疾病。
Curr Opin Neurol. 2007 Oct;20(5):572-6. doi: 10.1097/WCO.0b013e3282ef6064.
Zotero 插件